What Sets Us Apart

With operations in the US, Novotech is ideally positioned to offer clinical research services on the ground in both the US and Australia/New Zealand. There is an increasingly greater demand for CROs to offer services across these two regions providing the benefits of Australia’s highly regarded cost-effective clinical trial capabilities, and at the same time take advantage of access to the much larger US market for rapid patient enrolment.